Skip to main content
ONAPGO 4.9 mg/mL injection, solution by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc
ONAPGO, 4.9 mg/mL, injection, solution Drug class: Dopaminergic Agonist. Available on prescription only. Listed by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
Prescription only

ONAPGO

Apomorphine hydrochloride

Listed by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc

Strength
4.9 mg/mL
Form
Injection, Solution
Route
Subcutaneous
Class
Dopaminergic Agonist

What it contains

  • Apomorphine Hydrochloride 4.9 mg/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Drug class Dopaminergic Agonist
Approval route NDA — original brand approval
NDC code 27505-006
FDA application NDA214056
RxNorm concept 2705789
Package sizes listed 1
Marketed since February 2025

Other products containing Apomorphine

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

APOKYN

APOMORPHINE HYDROCHLORIDE

Strength
30 mg/3mL
Form
Injection
Class
Dopaminergic Agonist
Rx only

MDD US Operations, LLC

Not stocked by us — reference only

apomorphine hydrocloride

APOMORPHINE HYDROCHLORIDE

Strength
30 mg/3mL
Form
Injection
Class
Dopaminergic Agonist
Rx only Generic

TruPharma, LLC

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.